Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2013, Article ID 257381, 5 pages
http://dx.doi.org/10.1155/2013/257381
Clinical Study

Aqueous Concentrations of Vascular Endothelial Growth Factor in Eyes with High Myopia with and without Choroidal Neovascularization

1Department of Ophthalmology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan
2Department of Biomedical statistics, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan

Received 25 June 2012; Accepted 1 February 2013

Academic Editor: Edward Manche

Copyright © 2013 Taku Wakabayashi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [14 citations]

The following is the list of published articles that have cited the current article.

  • Wei Chen, Hui Song, Shiyong Xie, Quanhong Han, Xin Tang, and Yanhua Chu, “Correlation of Macular Choroidal Thickness with Concentrations of Aqueous Vascular Endothelial Growth Factor in High Myopia,” Current Eye Research, pp. 1–8, 2014. View at Publisher · View at Google Scholar
  • Qingjun Hu, Guohua Liu, Qing Deng, Qiuju Wu, Yong Tao, and Jost B. Jonas, “Intravitreal Vascular Endothelial Growth Factor Concentration And Axial Length,” Retina, vol. 35, no. 3, pp. 435–439, 2015. View at Publisher · View at Google Scholar
  • Yukimi Yamamoto, Dai Miyazaki, Shin-ichi Sasaki, Ken-ichiro Miyake, Shuzo Kaneda, Yoshifumi Ikeda, Takashi Baba, Atsushi Yamasaki, Yumiko Noguchi, and Yoshitsugu Inoue, “Associations Of Inflammatory Cytokines With Choroidal Neovascularization In Highly Myopic Eyes,” Retina, vol. 35, no. 2, pp. 344–350, 2015. View at Publisher · View at Google Scholar
  • Dan Zhu, Da-Yong Yang, Yuan-Yuan Guo, Yan-Fei Zheng, Jun-Lian Li, Bin Wang, Yong Tao, and Jost B. Jonas, “Intracameral Interleukin 1 beta, 6, 8, 10, 12p, Tumor Necrosis Factor alpha and Vascular Endothelial Growth Factor and Axial Length in Patients with C,” Plos One, vol. 10, no. 2, 2015. View at Publisher · View at Google Scholar
  • Bosch-Morell Francisco, Mérida Salvador, and Navea Amparo, “Oxidative Stress in Myopia,” Oxidative Medicine and Cellular Longevity, vol. 2015, pp. 1–12, 2015. View at Publisher · View at Google Scholar
  • Bum-Joo Cho, Joo Young Shin, and Hyeong Gon Yu, “Complications of Pathologic Myopia,” Eye & Contact Lens: Science & Clinical Practice, vol. 42, no. 1, pp. 9–15, 2016. View at Publisher · View at Google Scholar
  • O. A. Zhabina, E. A. Woods, and A. A. Plyukhova, “Modern views on myopic maculopathy,” Vestnik oftal'mologii, vol. 132, no. 1, pp. 85, 2016. View at Publisher · View at Google Scholar
  • A. G. Shchuko, N. V. Zaytseva, T. N. Yur’eva, E. R. Chernykh, I. M. Mikhalevich, and A. V. Grigor’eva, “Role of immunological factors in the development of myopic choroidal neovascularization,” Vestnik oftal'mologii, vol. 132, no. 5, pp. 5, 2016. View at Publisher · View at Google Scholar
  • Andrey G. Shchuko, Tatyana N. Yurieva, Isay M. Mikhalevich, Alina V. Grigorieva, Natalia V. Zaitseva, Elena R. Chernykh, and Ekaterina Y. Shevela, “Intraocular Cytokines and Their Correlations with Clinical Parameters in Patients with Myopic Choroidal Neovascularization,” Ophthalmologica, vol. 237, no. 2, pp. 96–104, 2017. View at Publisher · View at Google Scholar
  • Sebastian Wolf, Tien Yin Wong, Jennifer J. Arnold, Kyu Hyung Park, Michael Larsen, Kyoko Ohno-Matsui, Shih-Jen Chen, Chui Ming Gemmy Cheung, Frank G. Holz, Timothy Y.Y. Lai, and Paul Mitchell, “Myopic Choroidal Neovascularization: Review, Guidance, and Consensus Statement on Management,” Ophthalmology, vol. 124, no. 11, pp. 1690–1711, 2017. View at Publisher · View at Google Scholar
  • Kyoko Ohno-Matsui, Yasushi Ikuno, Timothy Y.Y. Lai, and Chui Ming Gemmy Cheung, “Diagnosis and treatment guideline for myopic choroidal neovascularization due to pathologic myopia,” Progress in Retinal and Eye Research, 2017. View at Publisher · View at Google Scholar
  • Kyoko Ohno-Matsui, Makoto Suzaki, Rie Teshima, and Nina Okami, “Real-world data on ranibizumab for myopic choroidal neovascularization due to pathologic myopia: results from a post-marketing surveillance in Japan,” Eye (Basingstoke), 2018. View at Publisher · View at Google Scholar
  • Chee Wai Wong, Yasuo Yanagi, Andrew Shih Hsiang Tsai, Waseem Ahamed Shihabuddeen, Ning Cheung, Shu Yen Lee, Jost B. Jonas, and Chui Ming Gemmy Cheung, “Correlation of axial length and myopic macular degeneration to levels of molecular factors in the aqueous,” Scientific Reports, vol. 9, no. 1, 2019. View at Publisher · View at Google Scholar
  • Federico Ricci, Giovanni Staurenghi, Monica Varano, Chiara Eandi, Tommaso Lupieri Sinibaldi, Laura Colombo, Marta Bartezaghi, and Stefania Bassanini, “OLIMPIC: a 12-month study on the criteria driving retreatment with ranibizumab in patients with visual impairment due to myopic choroidal neovascularization,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 257, no. 4, pp. 759–768, 2019. View at Publisher · View at Google Scholar